Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 10, Number 10—October 2004

Perspective

West Nile Virus Economic Impact, Louisiana, 2002

Armineh Zohrabian*Comments to Author , Martin I. Meltzer*, Raoult Ratard†, Kaafee Billah*, Noelle A. Molinari*, Kakoli Roy*, R. Douglas Scott*, and Lyle R. Petersen*
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †Louisiana Department of Health and Hospitals, New Orleans, Louisiana, USA

Main Article

Table 1

Costsa of inpatient treatment, by treatment/service category, for 119 patients with West Nile virus illness, Louisiana, 2002

Treatment/Service category nb Per patient costs ($)
Median Range Interquartile range Total costs ($)
Pharmacy/Medical supplies 115 2,934 16–88,825 994–7,601 887,759
Diagnostic 118 2,417 95–42,064 1,370–4,844 547,935
Room and board 117 1,132 52–16,445 640–2,266 237,917
Medical/Surgical services 75 675 15–21,606 183–3,261 200,233
Intensive care 24 5,526 439–17,769 2,320–11,001 162,360
Rehabilitationc 35 425 71–4,202 189–367 32,947
Emergency service 79 271 90–1,416 195–372 25,947
Other 33 109 1–2,620 20–247 8,873
Total 119 8,274 623–164,668 3,627–18,197 2,103,971

aEconomic costs were estimated on the basis of hospital charges, by using Medicare cost-to-charge ratio for Louisiana—0.41 for urban areas and 0.488 for rural areas.
bn, number of patients who incurred costs in this category among the 119 patients. Per patient statistics include only the patients who incurred costs in this category.
cRehabilitation costs indicated are those incurred during acute care hospital treatment. Costs of rehabilitation treatment in rehabilitation facilities are not included.

Main Article

TOP